Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

N/AActive Not RecruitingNCT05563883

University Hospital, Caen5,000,000 enrolled

Overview

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known. The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

Study Type

OBSERVATIONAL

Enrollment

5,000,000

Conditions

Atrial Fibrillation Cancer Thromboembolism Bleeding

Interventions

event occurenceOTHER

occurence of an event of interest: (AF, cancer, thromboembolism, bleeding, mortality...

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult hospitalized patients * with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information) Exclusion Criteria: * children

Locations (1)

Service de Cardiologie, Centre Hospitalier Universitaire Trousseau

Tours, France

Outcomes

Primary Outcomes

atrial fibrillation

occurrence of atrial fibrillation

Time frame: from inclusion in the cohort up to 10 years

cancer

occurrence of cancer

Time frame: ffrom inclusion in the cohort up to 10 years

Secondary Outcomes

thromboembolism

occurrence of thromboembolism

Time frame: from inclusion in the cohort up to 10 years

bleeding

occurrence of bleeding

Time frame: from inclusion in the cohort up to 10 years

mortality

occurrence of mortality

Time frame: from inclusion in the cohort up to 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.